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Abstract 
 In the present work, we have evaluated eight reportedly blood-specific 
mRNA markers (HBB, HBA, ALAS2, CD3G, ANK1, PBGD, SPTB and AQP9) in 
an attempt to determine the most suitable ones for use in forensic applications 
based on their sensitivities, specificities and performance with casework samples. 
While varying levels of expression were observed, all markers were relatively 
sensitive requiring as little as 1 ng of RNA input into the reverse transcription (RT) 
reaction. In singleplex reactions, seven of the eight analyzed blood markers (all 
except AQP9) demonstrated a high degree of specificity for blood. In multiplex 
reactions, non-reproducible cross-reactivity was observed for several of the 
mRNA markers, which was reduced and, in most cases, eliminated when less 
input total RNA was used. Additionally, some cross-reactivity was observed with 
tissue and animal samples. Despite differences in the observed sensitivity and 
specificity of the blood markers examined in this study, a number of the 
candidates appear to be suitable for inclusion in appropriately validated multiplex 
mRNA-based body fluid identification systems. 
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1. Introduction 
 The analysis of cell-specific mRNA expression has been proposed as a 
promising new method for the identification of body fluids. A number of mRNA 
markers have been identified for the forensically most relevant body fluids: blood, 
saliva, semen, vaginal secretions and menstrual blood [1-17]. RNA is notorious 
for its rapid post-mortem and in vitro decay, but several reports have pointed out 
an unexpectedly high stability of RNA in forensic stains [18-20]. 
 The purpose of this study was to take a critical look at the various blood 
mRNA markers that have been described in the literature and to perform a 
comparative analysis of their sensitivity, specificity and performance with 
casework samples. Blood was chosen for its easy availability, stability and the 
number of reported markers [6-10,13-14,16-17,19-20]. The following blood 
markers were included in the study: HBA and HBB are the alpha- and beta-
subunits of hemoglobin A [21,22]; aminolevulinate synthase 2 (ALAS2) is an 
erythroid-specific mitochondrial enzyme, that catalyzes the first step in the heme 
biosynthetic pathway [23]; CD3 gamma molecule (CD3G) is part of the T-cell 
receptor-CD3 complex, which plays an important role in coupling antigen 
recognition to several intracellular signal-transduction pathways [24]; ankyrin 1 
(ANK1) is an erythrocyte membrane protein, which provides the primary linkage 
between the membrane skeleton and the plasma membrane [25]; the erythroid 
form of porphobilinogen deaminase (PBGD) is the third enzyme of the heme 
biosynthetic pathway [26]; β-spectrin (SPTB) is an erythrocyte membrane protein 
[27]; Aquaporin (AQP9) is a water channel protein expressed in peripheral 
leukocytes [28]. AQP9 was chosen as one representative out of nine, all of which 
were stated by the authors [13] to be co-expressed in vaginal secretion. 
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 In the present study the eight reportedly blood specific mRNA markers 
listed above were tested in order to evaluate specificity and sensitivity. Initial 
experiments were conducted using singleplex reactions to determine which of the 
eight markers would be most suitable for inclusion in a blood identification 
multiplex system. Cross reactivity with several body fluids in addition to blood was 
observed for AQP9 and therefore it was excluded from further analyses. Two 
multiplex systems were developed using the remaining seven markers allowing 
for the simultaneous amplification of two (high sensitivity duplex with HBA and 
HBB) and five mRNA markers (medium sensitivity pentaplex with ALAS2, ANK1, 
CD3G, SPTB, and PBGD) in single PCR reactions. The specificity, sensitivity and 
suitability of use with forensic casework samples for both multiplex systems were 
evaluated. Additionally, the ability to identify the presence of blood in challenging 
environmentally compromised blood samples was demonstrated for both 
multiplex systems.  
 
2. Materials and methods 
Samples 
 Body fluids were collected from healthy volunteers with their informed 
consent. 10 µl or 50 µl aliquots of fresh blood (without anticoagulation treatment) 
or EDTA-blood or saliva or frozen semen were pipetted on cotton swabs and 
dried at room temperature. Vaginal secretions and menstrual blood were 
collected from the vagina on sterile cotton swabs and dried at room temperature. 
Altogether, samples from 26 different donors were used for the initial sensitivity / 
specificity experiments and samples from 17 different donors for the specificity 
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studies with the multiplexes. For the dilution series EDTA-blood from 6 different 
donors was diluted in 0.9% NaCl to a final volume of 5 µl per swab. 
  Stains tested included 3 samples from proficiency trials / interlaboratory 
exercises and 28 forensic casework samples from 16 routine cases. Blood stains 
comprised swabs from various surfaces (e.g. floor, window sill, doorknob, knife, 
glass) and blood on different objects (e.g. clothing, shoes, wood, paper). Two 
stains were 2 and 11 years old, the others were less then a year old. 
 For the environmentally compromised bloodstains, 50 µl aliquots of human 
blood were dried onto cotton cloth. These samples were exposed to different 
environmental conditions including various temperatures and environmental 
influences including humidity and rain. The environmental conditions were as 
follows: (i) room temperature storage (22oC), (ii) 37oC storage, (iii) outside 
covered (OC) – exposed to heat, light and humidity, and (iv) outside uncovered 
(OUC) – exposed to heat, light, humidity and rain. Samples from all sets of 
conditions were collected at varying lengths of time and the following samples 
were used in the present study: room temperature (6 months, 1 year), 37oC (1 
month – 1 year), OC (1 day -1 month), and OUC (1 day – 1 month). Temperature 
ranges, humidity levels, and amount of rain were recorded for the samples placed 
in outside conditions.  
 EDTA-blood samples from 18 non-primate animal species (alligator, cat, 
cow, deer, dog, duck, ferret, frog, guinea pig, goat, horse, mouse, opossum, pig, 
rabbit, rooster, sheep, turtle) and 10 primate species (African green monkey, 
baboon, black howler monkey, chimpanzee, crab-eating macaque, pig-tailed 
macaque, rhesus monkey, spider monkey, spot-nosed guenon) were obtained 
from various sources: HemoStat Laboratories, Dixen, CA (cow, horse); Central 
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Florida Zoo, Sanford, FL (brown lemur, howler monkey, spot-nosed guenon); 
Biorecalamtion, Inc., Westbury, NY (alligator, cat, deer, dog, duck, frog, goat, 
mouse, opossum, pig, rabbit, rooster, sheep, turtle, African green monkey, 
baboon, chimpanzee, crab-eating macaque, rhesus monkey); Innovative 
Research, Novi, MI (guinea pig); YERKES National Primate Research Center, 
Emory University, Atlanta, GA (pig-tailed macaque); Marshall Farms, North Rose, 
NY (ferret); Laboratory donation (spider monkey); Animal hospital, University of 
Zurich, Switzerland (cat, dog); Institute of laboratory animal services, University of 
Zurich, Switzerland (mouse, rabbit, rat). For all blood samples, 50 µl aliquots 
were placed on cotton cloth and dried overnight at room temperature.  
 Total RNA from 20 human tissues (adipose, bladder, brain, cervix, colon, 
esophagus, heart, kidney, liver, lung, ovary, placenta, prostate, skeletal muscle, 
small intestine, spleen, testes, thymus, thyroid, and trachea) included in the 
FirstChoice® Human Total RNA Survey Panel was obtained from Applied 
Biosystems/Ambion (Austin, TX). All tissues included in the panel were 3-donor 
pooled samples. Total RNA from human skin was obtained from Biochain 
Institute, Inc (Hayward, CA).  
 
RNA extraction 
 Total RNA was extracted manually (i.e. organic extraction) as described 
previously [6] or with column-based kits (RNeasy Mini Kit or AllPrep DNA/RNA 
Mini Kit, Qiagen, Hombrechtikon, Switzerland and Germantown, MD), according 
to the manufacturer’s protocol, with some adaptations [14]. Casework and 
environmentally compromised bloodstains were incubated at 56oC for up to three 
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hours in RLTplus buffer for improved extraction and recovery of RNA from 
challenging samples.  
 
DNase treatment 
 Contaminating DNA was removed with the TURBO DNA-free kit (Applied 
Biosystems/Ambion AB, Rotkreuz, Switzerland and Austin, TX) or on-column with 
the RNase-free DNase set (Qiagen) according to the manufacturer’s protocol. 
 
RNA quantification 
 RNA was quantified as described previously [6] or with the Quant-iT RNA 
assay kit and the Qubit fluorometer (Invitrogen, Basel, Switzerland), according to 
the manufacturer’s protocol. 
 
Reverse transcription 
 For the reverse transcription (RT) reaction, the SuperScript III First-Strand 
Synthesis System for RT-PCR (Invitrogen), random primer protocol, was used 
according to the manufacturer’s instructions. Alternatively SuperScript III reverse 
transcriptase, 50 ng random primers and RNaseOUT (all from Invitrogen) were 
used for the RT reaction. cDNA was obtained in a final volume of 20  µl. 
Appropriate volumes of total RNA extracts were utilized in the reverse 
transcription reactions in order to obtain a desired quantity. For those samples 
with insufficient quantities, a maximum volume of extract (8 or 11 µl, depending 
on the RT kit) was used. RT minus controls (without reverse transcriptase) were 
included (using the sample input quantities or extract volumes as the RT positive 
reactions) in order to identify possible genomic DNA contamination.  
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Endpoint PCR 
 HPLC-purified primers were purchased from Microsynth (St. Gallen, 
Switzerland). Primers for the amplification of gene specific sequences were 
obtained from published sources [6, 13, 14, 16]. Additional primer sets were 
designed for HBA, ANK1 and CD3G, using the Primer3 Software (Electronic 
supplementary data, Table S1). All primers were designed to overlap exon-exon-
junctions or span an intron in order to ensure that the obtained products were not 
due to the presence of contaminating DNA. The forward primers were 5’-labelled 
with 5’-FAM.  
 The following amplification conditions were used for the singleplex PCR 
reactions: The 25 µl reaction mix contained 3 µl cDNA or an equal amount of 
sterile water for non-template controls, 2 µl primer mix (see below), 1mM dNTPs 
(AB), 1x PCR Buffer I (AB), and 1.25U AmpliTaq Gold DNA Polymerase (AB). 
Primer concentrations were as follows: HBB 0.04 µM, HBA 0.027 µM, ALAS2 
0.08 µM, CD3G 0.8 µM, ANK1 0.8 µM, PBGD 0.8 µM, SPTB 0.8 µM, AQP9 0.04 
µM. The amplification was performed on a GeneAmp PCR System 9700 (AB): 
The initial denaturation was at 95°C for 11 min, followed by 35 cycles of 94°C 20 
s, 55°C 30 s, 72°C 40 s and the final elongation at 72°C for 5 min.  
 Optimization of two multiplex systems, duplex (HBB, HBA) and pentaplex 
(CD3G, ANK1, ALAS2, PBGD, SPTB) resulted in a set of standard amplification 
conditions. (duplex) – The 25 µl reaction mix contained 3 µl cDNA, 2.5 µl primer 
mix (see below), 1mM dNTPs (AB), 1x PCR Buffer II (AB, US amplifications) or 
1x Gold Buffer (AB, Switzerland amplifications), 3 mM MgCl2 (AB), and 1.5U 
AmpliTaq Gold DNA Polymerase (AB); (pentaplex) - The 25 µl reaction mix 
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contained 5 µl cDNA, 2.5 µl primer mix (see below), 1mM dNTPs (AB), 1x PCR 
Buffer II (AB, US amplifications) or 1x Gold Buffer (AB, Switzerland 
amplifications), 3 mM MgCl2 (AB), and 1.5U AmpliTaq Gold DNA Polymerase 
(AB). Sterile water was used in place of cDNA for non-template controls. The 
primer mixes were prepared using the following concentrations: (duplex) - HBB 
0.1 µM, HBA 0.1 µM, (pentaplex) - ALAS2 0.15 µM, CD3G 0.25 µM, ANK1 0.2 
µM, PBGD 0.8 µM, SPTB 0.25 µM. The amplification was performed on a 
GeneAmp PCR System 9700 (AB): The initial denaturation was at 95°C for 11 
min, followed by 25 cycles (duplex) or 35 cycles (pentaplex) of 94°C 20 s, 57°C (+ 
0.2°C per cycle) 30 s, 72°C 40 s and the final elongation at 72°C for 60 min. Post 
PCR purification was performed with the MinElute PCR purification kit (Qiagen) 
according to the Manufacturer’s protocol, elution in 10-50 µl EB buffer. 
 
Capillary electrophoresis 
 PCR products were separated and detected with a 3130 or 3130xl Genetic 
Analyzer (AB). One microliter of the amplified sample was added to 9.7 µl Hi-Di 
Formamide and 0.3 µl of GeneScan-500 LIZ (3130) or 12.75 µl Hi-Di Formamide 
and 0.25 µl of GeneScan-500 LIZ (3130xl) (all from AB). The following 
electrophoresis conditions were used for the 3130 / 3130xl Genetic Analyzers: 
16s / 18s injection time, 1.2 kV injection voltage, 15 kV run voltage, 60°C, 20 min. 
run time, Dye Set G5 (6-FAM, VIC, NED, PET, LIZ). Raw data were analyzed 
with the Genemapper Software (AB). A peak detection threshold of 100 RFUs 
was used for positive marker identification calls. 
 
DNA-extraction, amplification, quantification, detection 
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 DNA was co-extracted with the AllPrep DNA/RNA Mini Kit (Qiagen) and 
eluted in 80-100  µl EB buffer, and for the sensitivity studies additionally 
concentrated with Microcon-30 centrifugal filter devices (Millipore, Zug, 
Switzerland) to 20  µl. Conventional Chelex extraction was performed according 
to standard protocols, followed by ultrafiltration with Amicon Ultra-4 Centrifugal 
filter devices (Millipore) to a final extract volume of approximately 100  µl. DNA 
was quantified with the Quantifiler® Human DNA Quantification kit (AB) according 
to the Manufacturer’s instructions. 5 µl DNA (forensic stains) or 10 µl DNA 
(serially diluted blood samples) or 1 ng DNA / max. volume (environmentally 
compromised stains) were amplified with the SGMplus multiplex Kit (AB) in a total 
reaction volume of 25 µl on a GeneAmp PCR System 9700 (AB) according to the 
manufacturer’s protocol. PCR products were detected with a 3130 or 3130xl 
Genetic Analyzer (AB). One microliter of the amplified sample was added to 9.7 
µl Hi-Di Formamide and 0.3 µl of GeneScan-500 ROX (3130) or 12.5 µl Hi-Di 
Formamide and 0.5 µl of GeneScan-500 ROX (3130xl) (all from AB). The 
following electrophoresis conditions were used for the 3130 / 3130xl Genetic 
Analyzers: 16s / 18s injection time, 1.2 kV injection voltage, 15 kV run voltage, 
60°C, 20/25 min. run time, Dye Set F (5-FAM, JOE, NED, ROX). Raw data were 
analyzed with the Genemapper Software (AB). A peak detection threshold of 50 
RFUs was used. 
 
3. Results 
3.1. Singleplexes 
 Initial experiments were designed to attempt to confirm the specificity of 
the eight reportedly blood-specific mRNAs (HBB, HBA, ALAS2, CD3G, ANK1, 
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PBGD, SPTB and AQP9). The sensitivity of each marker was also evaluated 
using singleplex reactions to determine which of the confirmed blood-specific 
markers should be included in subsequent multiplex development and validation 
studies. Total RNA was isolated from body fluid samples (blood, saliva, buccal 
swabs, semen, vaginal secretions, menstrual blood) from 26 different donors 
using a manual organic extraction. Fifty, ten and one nanogram of total RNA was 
reverse transcribed and cDNA amplified with singleplex PCR reactions. The use 
of 1 or 10 ng of total RNA appeared to be sufficient for detection of the mRNAs 
(Table 1). An inhibitory effect in the blood samples and an increase in the 
occurrence of false negative results in the non-blood samples was observed with 
50 ng of input total RNA (Table 1). The manufacturer’s protocol for the TURBO 
DNA-free kit recommends that the volume of extract should not exceed 20-40% 
of the final RT-PCR reaction volume. Therefore, it is possible that the observed 
inhibition was due to the use of extract volumes exceeding the suggested 
maximums. The buffer included in the kit could possibly contain EDTA and 
therefore the recommended volumes are designed to prevent inhibition of 
subsequent RT reactions that may be sensitive to the amount of MgCl2. 
Alternatively, a small level of carry-over of the inactivation resin into subsequent 
reactions could also affect efficiency as it is designed to sequester divalent 
cations (i.e. MgCl2). 
 No reaction with up to 25 ng genomic DNA was ever observed with any of 
the tested blood markers (data not shown). Cross reactivity with vaginal secretion 
and low expression in saliva was confirmed with the RNA marker AQP9, which 
therefore was excluded from further investigations. Occasionally other false 
positive reactions were detected with 50 ng and 10 ng of input total RNA, but 
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normally significantly smaller peaks than those observed for the blood samples 
(Table 1). 
 
3.2. Multiplexes 
 An advantage of mRNA profiling for body fluid identification includes the 
ability to multiplex numerous markers allowing for built-in redundancy to account 
for possible biological variation in gene expression levels. Initial testing 
demonstrated that HBA and HBB are expressed abundantly in blood, whereas 
the other 5 blood markers are expressed moderately or low. Therefore two 
multiplex systems were designed in order to allow for the use of optimized 
amplification conditions to accommodate the differing sensitivities of the mRNA 
markers. A high-sensitivity duplex (25 PCR amplification cycles), including HBA 
and HBB, and a medium-sensitivity pentaplex (35 PCR amplification cycles), 
including ALAS2, CD3G, ANK1, PBGD and SPTB, were developed. Figure 1 
shows representative electropherograms from a known bloodstain (duplex – Fig. 
1c and 1d pentaplex – Fig. 1a and 1b) using 1 ng of input RNA. The high 
sensitivity of the duplex system can be seen with the strong signal intensity of the 
obtained HBB and HBA peaks. No extraneous peaks were observed at marker 
positions in the RT- or PCR negative controls (data not shown). However, 
saturation-mediated peaks (approximately 10 bp smaller than the true peak) were 
frequently observed due to the high sensitivity of this multiplex system (Fig. 1c). 
While simultaneous amplification of the markers included in the pentaplex was 
achieved, there were additional challenges with this multiplex. First, complete 
signal intensity balance was not achieved due to the differing levels of expression 
of the included markers (low to moderate). Additionally, an increased occurrence 
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of split peaks and noisy baselines were observed with the pentaplex system 
compared to the duplex system. No amplification peaks at marker positions were 
observed in the RT minus or PCR negative controls (data not shown). However, 
dye blobs at 60 bp and 220 bp were frequently observed. The appearance of 
saturation peaks as well as dye blobs was reduced and in many cases eliminated 
with the use of post PCR purification (Fig. 1b and 1d). The use of post-PCR 
purification also resulted in increased signal intensity, which was useful with 
detection of the lower abundance markers in the pentaplex system. 
 
3.3. Sensitivity 
 Multiplex sensitivity was tested in two ways, a practical approach 
(bloodstain size) and a quantitative (input total RNA) approach. For the practical 
approach, serially diluted bloodstains (containing 5, 1, 0.1, 0.01, 0.001 µl blood) 
were extracted using various nucleic acid isolation methods: Qiagen AllPrep 
DNA/RNA Mini Kit (8 diluted bloodstain sets from 5 different donors), manual 
organic RNA extraction (5 diluted bloodstain sets from 4 different donors) and, for 
comparison to a non-co-isolated RNA method, conventional DNA Chelex 
extraction (3 diluted bloodstain sets from 3 different donors). Total RNA was 
reverse transcribed (Qiagen AllPrep DNA/RNA Mini kit: 11 µl RNA, manual RNA 
extraction: 1-8 µl RNA, because too much TURBO-DNase-treated RNA inhibited 
the RT reaction) and amplified with the duplex and pentaplex multiplex systems. 
The results for the co-isolation (Qiagen AllPrep DNA/RNA Mini kit) and the 
manual organic extraction were very similar (Table 2). Most markers could detect 
as little as 0.1 µl of blood. Several of the markers (HBB, HBA, ALAS2 and CD3G) 
were detected in 0.01 µl of blood. With conventional Chelex extraction, using 5 µl 
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DNA for amplification, full SGMplus profiles were obtained with as little as 1 µl 
blood, partial profiles with 0.1 µl blood and no result for 0.01 and 0.001 µl blood. 
The SGMplus profiles from the co-extracted DNA were slightly worse in that 5 µl 
blood was required for full profiles to be obtained. Partial DNA profiles were 
obtained for 0.01 - 1 µl of blood; however, frequently only individual loci were 
observed for bloodstains < 1 µl, although this DNA was additionally concentrated 
with Microcon centrifugal filter devices and 10 µl DNA was amplified.  
 For the quantitative approach a dilution series of manually extracted RNA 
(10, 1, 0.1, 0.01, 0.001, 0.0001 ng) from bloodstains from 5-6 different individuals 
was reverse transcribed and amplified with the duplex and pentaplex multiplex 
systems (Table 3). HBB and HBA appeared to be the most sensitive markers, 
detecting as little as 0.001 ng of input total RNA. ALAS2, CD3G, ANK1 and SPTB 
showed a medium sensitivity with a detection limit of 0.1 to 0.01 ng of input total 
RNA, and PBGD was the least sensitive marker with a detection limit of 0.1 ng 
input total RNA.  
 
3.4. Forensic casework and mock casework stains 
 Three blood stains from proficiency trials / interlaboratory exercises and 28 
casework blood samples obtained from 16 routine cases were extracted with the 
Qiagen AllPrep DNA/RNA Mini Kit. Eleven microliters of total RNA were reverse 
transcribed and 3 and 5 µl of cDNA amplified with the duplex and pentaplex 
multiplex systems, respectively. From 25 of the 31 blood stains at least 3 out of 
the 8 mRNA markers were detected enabling a positive identification of blood, 
with concomitant full SGMPlus profiles (Table 4). Several bloodstains with low 
amounts of extracted DNA (stain #s 8, 25 and 31), exhibited DNA profiles but no 
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RNA profiles. Blood stain #16 which also contained low amounts of DNA, 
produced a partial DNA profile together with a good RNA profile. For one sample 
(#3), a 2 year old blood stain on leather, only one of the blood mRNA markers 
was detected (HBB) and no DNA profile could be recovered. This could be due to 
the presence of inhibitors or the inability to recover sufficient amounts of 
biological material from this type of substrate for successful analysis.  
 
3.5. Environmentally exposed stains 
 A set of blood stains from a male and female donor (an additional female 
donor for the outside uncovered sample set was used due to unavailability of the 
original female donor  for that exposure condition only) were exposed to a range 
of environmental conditions from 1 day to 1 year. For all of the samples except 
two, 3-7 mRNA markers were detected allowing for a successful identification of 
the presence of blood (Table 5). Only HBB and HBA were detected for two 
outside samples (outside covered 3 days and outside uncovered 1 month), which 
demonstrates the suitability of use of the high sensitive duplex with challenging or 
more highly degraded casework samples. Additionally, full STR profiles were 
obtained from a majority (79%) of samples (Table 5). For five of the seven 
samples where a full profile was not obtained, partial profiles were recovered. No 
profile was obtained from the bloodstains from both the male and female donors 
that had been placed outside uncovered for 1 month. However, detection of the 
presence of blood (2 mRNA markers for the female sample and 5 mRNA markers 
for the male sample) was observed for these samples.  
 
3.6. Specificity 
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 Initial evaluations of the specificity of the 7 blood markers in singleplex 
reactions indicated a high level of specificity for blood. In order to ensure that 
equivalent specificity would be obtained with the markers in the two multiplex 
formats, additional human biological fluid samples (blood, semen, saliva (liquid 
and buccal swabs), vaginal secretions, and menstrual blood) as well as twenty-
one human tissues (adipose, bladder, brain, cervix, colon, esophagus, heart, 
kidney, liver, lung, ovary, placenta, prostate, skeletal muscle, skin, small intestine, 
spleen, testes, thymus, thyroid, and trachea) were analyzed. Body fluids included 
4 sets of blood (4 donors), saliva (3 donors), buccal swabs (4 donors), semen (4 
donors), vaginal secretions (2 donors) and menstrual blood (4 donors) from 17 
different donors. 2 body fluids sets comprised 50 µl blood, saliva or semen on 
swabs and whole buccal, vaginal and menstrual blood swabs, the other 2 sets 
comprised 10 µl blood, saliva or semen on swabs and quarter buccal, vaginal and 
menstrual blood swabs. The swabs / quarter swabs were extracted using the 
manual organic extraction and 1 ng of total RNA was reverse transcribed followed 
by amplification with the duplex and pentaplex multiplex systems. The cDNA from 
the different body fluids was first tested with body fluid specific markers in a 10-
plex [14], to be sure that the extraction and reverse transcription steps were 
successful. Most of the 7 blood markers were present in the 4 blood samples and 
the 4 menstrual blood samples and there was no cross-reactivity with other body 
fluids (Table 6). Occasional false positive reactions appeared, but these results 
were not reproducible in up to 3 identical PCR reactions (data not shown). When 
higher amounts of RNA were reverse transcribed, the occurrence of single 
marker false positive results increased irrespective of the extraction method and 
DNase treatment used (data not shown) thereby demonstrating, similar to DNA 
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analysis, the need for quantification to ensure that analytically optimal amounts of 
RNA are used.  
 In order to further evaluate the specificity of the blood markers, 1 ng of 
total RNA from human tissues was reverse transcribed and cDNA amplified with 
the duplex and pentaplex multiplex systems. Detection of multiple blood markers 
was observed for all tissues except placenta (Electronic supplementary data, 
Table S2a). Based on these initial results, the specificity of the blood markers 
does not appear to be absolute. However, capillaries will likely be present in 
tissue samples in order to supply blood to the various tissues. Therefore, it is not 
possible to preclude the possibility that capillary blood is being detected in the 
tissue samples. Additionally, the total RNA from these tissues was obtained from 
commercial sources and not extracted in-house from actual tissue samples. Such 
RNA will be of superior quality to that obtained from dried biological stains (i.e. 
less degraded and with a larger number average molecular weight) and may 
therefore effectively contain for each tested gene transcript a larger number of full 
length starting templates per ng of input total RNA. This might result in false 
positive reactions. Ideally, to confirm this hypothesis, total RNA extracts from 
dried tissue samples from clearly defined sources should be tested.  
 The species specificity of the blood markers was evaluated with 1 ng of 
total RNA isolated from animal and primate blood samples. The RNA was reverse 
transcribed and cDNA amplified with the duplex and pentaplex systems. 
Detection of all seven markers was not observed for any or the animal or primate 
samples (Electronic supplementary data, Table S2b). HBB was the only marker 
not detected in any of the animal samples. However, detection of the remaining 
markers in some domestic animals including cat, dog, guinea pig, mouse, rabbit, 
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rat and turtle was observed. This initial specificity testing was mainly performed 
with one sample per species and may therefore require additional testing with 
multiple samples within a species in order to make a more definitive assessment 
of the species specificity of these blood markers.  
 
4. Discussion 
 The purpose of this study was to critically evaluate the various mRNA 
blood markers that have been described in literature and to compare their 
sensitivity, specificity and performance with casework samples. The focus of this 
study was on blood which is a frequently encountered biological fluid in forensic 
casework and for which a larger number of gene candidates have been reported. 
Eight putative blood specific mRNA markers were tested in an initial screening 
experiment, with a limited number of samples, for their efficacy to positively 
identify blood, namely HBB, HBA, ALAS2, CD3G, ANK1, PBGD, SPTB and 
AQP9. Cross-reactivity of AQP9 with vaginal secretion and low expression in 
saliva was stated by the authors [13] and confirmed in our pre-evaluation and 
therefore was excluded from further investigations. 
 An advantage of mRNA profiling is the ability to multiplex numerous 
markers for the identification of one or several body fluids. It was not the primary 
intention of the authors to create a ready-to-use multiplex for the identification of 
blood, but instead to evaluate a set of blood markers under the same conditions 
for direct comparisons of their specificity, sensitivity and performance with 
casework samples. The optimization of a single multiplex system was challenging 
due to significant differences in marker abundance and/or amplification 
efficiencies. However, the development of separate high- and medium-sensitivity 
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multiplex systems permitted their facile optimization. HBB and HBA were 
incorporated into the high-sensitivity duplex, which performed robustly across a 
wide range of forensic samples and varying levels of input. The pentaplex, which 
includes ALAS2, ANK1, CD3G, PBGD and SPTB, demonstrated additional 
multiplex design issues (e.g. split peaks, noisy baseline) and would therefore 
likely need further optimization. The multiplex systems were primarily developed 
for ease of marker validation and are not necessarily recommended in their 
current form for routine use in casework analysis. The use of post-PCR 
purification improved the quality of the multiplex results (reduced appearance of 
split peaks, dye blobs, etc) and was a disincentive to develop additional 
modifications that would further improve profile quality to a casework acceptable 
level. 
 The two RNA- and the two DNA-extraction methods were compared by the 
analysis of serially diluted blood samples. The manual RNA extraction method 
and the AllPrep DNA/RNA co-extraction kit provided similar RNA results, 
permitting the identification of as little as 0.1-0.01 µl blood. These results 
demonstrate that a sufficient amount of total RNA can be recovered from small-
volume bloodstains using a co-isolation strategy and does not result in any 
reduced typing success. Sensitivity results coincide perfectly with the results of a 
collaborative exercise, identifying blood with the 3 markers HBB, SPTB and HBB 
as singleplexes [16]. HBB was shown to be expressed abundantly in blood 
(detection of 0.001 µl blood), SPTB moderately (detection of 0.1 µl blood) and 
PBGD significantly less (detection of 1 µl blood), in spite of different analysis 
strategies and inter-laboratory variation. The manual Chelex DNA extraction 
performed slightly better than the AllPrep DNA/RNA co-extraction kit in obtaining 
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a full DNA profile, with the former only requiring 1 µl blood. The use of enhanced 
DNA typing strategies for low template (LT) or degraded DNA (e.g. increased 
cycle numbers, whole genome amplification WGA, low volume amplification, post 
PCR purification, miniSTRs) with either approach could possibly improve typing 
results of such small stains [29-34]. 
 A positive control consisting of a marker expressed in all tissue types 
would confirm a successful analysis. However, currently no housekeeping gene is 
described that is suitable for the detection of all tested body fluids. Saliva and 
semen, for example, show very little or no expression of common housekeeping 
genes (GAPDH, 18S rRNA, TEF, UCE), presumably because of limited cell 
metabolism in spermatozoids and the desquamated cells of the cheek mucosa 
[14,17]. Additionally, the high abundance of housekeeping genes relative to 
mRNA may result in the titration of critical PCR components thereby affecting the 
overall sensitivity of the multiplex system. Co-extracted DNA might serve as a 
positive control for the presence of human cells. A concurrent negative RNA 
result would suggest that no human blood is present or that the mRNA is 
degraded and no result can be obtained. In the case of degradation, 
housekeeping genes  would also be affected. 
 Remarkably low quantities of total RNA were needed to obtain a complete 
mRNA profile from blood. With 1 ng RNA all blood markers were detectable, but 
even with 0.001 ng RNA HBA, HBB and occasionally additional markers were 
detected. It proved to be important for the specificity of the method not to put too 
much RNA into the RT reaction and the optimal input is somewhat dependent 
upon the particular DNase treatment and buffers used. 
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 The seven tested blood mRNA markers performed well with casework and 
environmentally exposed samples. From almost all stains a good quality DNA 
profile and the positive identification of blood could be achieved. Even stains 
exposed to humidity and rain for up to one month could be identified as blood, 
despite no DNA profile being generated. The successful identification of blood 
using the two multiplex systems and the recovery of STR profiles from a majority 
of the samples tested indicate the potential suitability of use of this type of 
profiling approach (co-isolation followed by mRNA and STR profiling) in forensic 
casework. Improved analysis of degraded and highly compromised samples may 
be achieved in the future through the use of small RNA profiling (e.g. microRNA) 
[35-36]. 
 There was no cross-reactivity with other body fluids, except for occasional, 
but not reproducible, false positive reactions for single markers. Not much inter-
individual differences in body fluid specific RNA expression were observed 
among the tested individuals, but further validation of the multiplex systems 
should include the evaluation of additional donors. Based on the results of this 
study with 50 ng of input total RNA, it became apparent that it is essential to 
quantify the RNA and put a defined amount (not more than 10 ng) into the RT 
reaction in order to avoid false positive signals. The sensitive and convenient 
fluorescence based RNA quantification methods employed here will have limited 
casework utility because they are not human specific. Thus bacterial RNA, which 
is found in abundance in buccal or vaginal swabs, will result in an underestimate 
of the amount of human RNA in these sample types. Accurate quantification of 
human total RNA in forensic samples awaits the development of a human specific 
RNA quantification system. Additionally, the occasional false positive reactions 
  22/38 
could be the result of the use of high number of amplification cycles (35 cycle 
PCR reaction for the pentaplex system), with extremely low initial copy number of 
cDNA molecules. The use of high cycle number for low template DNA samples 
often results in the appearance of foreign alleles (“allele drop-in”) [29] and the 
same effects might also be observed with RNA multiplex systems. The identified 
blood specific mRNAs, while expressed abundantly in blood, are likely not to be 
completely absent in other cells. Therefore, it is critical that optimal reaction 
conditions as well as RNA input amounts be used in order to obtain accurate 
profiling results.  
 Some cross-reactivity of the RNA multiplexes with human tissues and 
animal blood was observed. Cross reactivity with human tissues could be 
ascribed to blood-supplying capillaries, which are likely present in tissue samples. 
This finding is not desirable, but nevertheless not that disturbing, since tissues 
don’t appear frequently in crime cases, unless a severely traumatized corpse is 
involved. Cross reactivity with animal blood was expected for non-human primate 
species, which shouldn’t be a problem from the forensic point of view, since non-
human primates are normally not involved in crime cases. The cross reactivity 
with other non-primate animal species (e.g. domestic animals), however, was 
unexpected and undesirable, as occasional contact with some of these animals at 
crime scenes is possible. No more than three markers were detected in a single 
animal species and therefore the inclusion of multiple blood markers in a mRNA 
body fluid identification multiplex system could allow for a determination of 
species if appropriate combinations of markers were selected. In addition the co-
extracted DNA would not show a result with human specific STR multiplexes, 
another requirement for the definite identification of human blood. 
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 In summary, the results of this study support the use of mRNA profiling for 
the positive identification of a forensically relevant biological fluid, namely blood. 
Based on the observed specificities and sensitivities of the blood mRNA 
candidates, informed selections of the appropriate markers to be included in body 
fluid identification systems can be made. While the results in this study were 
obtained using a CE-based detection platform, the future of mRNA profiling in 
forensics could be a "body fluid identification chip" containing a low density array 
of cDNAs that would be able to interrogate a comprehensive set of candidate 
genes for each body fluid. Therefore, it is essential that additional testing and 
validation studies be performed on new candidates for all forensically relevant 
biological fluids in order to develop robust RNA profiling systems for use in 
forensic casework.  
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Tables and Figures 
 
 
Table 1: Results of initial specificity and sensitivity testing for eight blood-specific 
mRNA markers using singleplex PCR reactions. Numbers represent the average 
peak height in rfu for (x) tested donors. The dark grey squares show positive 
results for all donors tested; light grey squares positive results for some, but not 
all, donors tested; white squares negative results for all donors tested. Except for 
AQP9 the false positive peaks were significantly smaller than those observed for 
the blood samples. 
 
50 ng RNA into RT
Body fluid HBB HBA ALAS2 CD3G ANK1 PBGD SPTB AQP9
blood 5155 (3) 5807 (4) 383 (3) 1182 (3) 3088 (4) 0 (3) 1153 (3) 438 (4)
saliva 46 (3) 29 (4) 0 (3) 0 (3) 0 (4) 0 (3) 0 (3) 2405 (4)
buccal swab 50 (3) 104 (4) 0 (3) 0 (3) 0 (4) 0 (3) 0 (3) 1092 (4)
semen 0 (3) 0 (4) 0 (3) 0 (3) 0 (4) 0 (3) 0 (3) 0 (4)
vaginal secretions 0 (3) 0 (4) 0 (3) 0 (3) 0 (4) 0 (3) 346 (3) 6495 (4)
menstrual blood 7877 (3) 5473 (4) 2086 (3) 3929 (3) 2251 (4) 0 (3) 2085 (3) 6573 (4)
10 ng RNA into RT
Body fluid HBB HBA ALAS2 CD3G ANK1 PBGD SPTB AQP9
blood 7790 (4) 8217 (4) 3901 (4) 7907 (4) 8340 (4) 3511 (4) 6011 (4) 9571 (3)
saliva 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 118 (3)
buccal swab 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 708 (3)
semen 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (3)
vaginal secretions 0 (4) 0 (4) 0 (4) 495 (4) 0 (4) 0 (4) 0 (4) 2690 (3)
menstrual blood 5588 (4) 4579 (4) 117 (4) 1124 (4) 618 (4) 0 (4) 411 (4) 3751 (3)
1 ng RNA into RT
Body fluid HBB HBA ALAS2 CD3G ANK1 PBGD SPTB AQP9
blood 7444 (4) 8125 (4) 3653 (4) 8016 (4) 7056 (4) 611 (4) 4075 (4) 2195 (2)
saliva 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 108 (2)
buccal swab 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 105 (2)
semen 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (2)
vaginal secretions 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 0 (4) 1828 (2)
menstrual blood 3434 (4) 4353 (4) 0 (4) 1272 (4) 459 (4) 0 (4) 0 (4) 858 (2)
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Table 2: Sensitivity of the RNA and DNA profiling methods using practical 
approach (bloodstain size). DNA and RNA from 0.001 µl – 5 µl bloodstains were 
extracted individually using a manual organic (RNA) and Chelex (DNA) 
extraction, or co-extracted using the Qiagen AllPrep DNA/RNA Mini kit. Each 
experiment was carried out 3-8 times, with blood from different donors. RNA was 
reverse transcribed (Qiagen AllPrep DNA/RNA Mini kit: 11 µl RNA, manual RNA 
extraction: 1-8 µl RNA, because too much TURBO-DNase-treated RNA inhibited 
the RT reaction) and amplified with the multiplexes. The dark squares represent 
positive results in all experiments, grey squares show positive results in some but 
not all experiments, white squares represent no positive result.  
 
 
RNA manual extraction DNA Chelex extraction
blood HBB HBA ALAS2 CD3G ANK1 PBGD SPTB D3 vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA
5 ul 5/5 5/5 5/5 5/5 5/5 5/5 5/5 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3
1 ul 5/5 5/5 5/5 5/5 4/5 2/5 2/5 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3
0.1 ul 5/5 5/5 5/5 4/5 2/5 0/5 2/5 3/3 3/3 3/3 2/3 3/3 3/3 3/3 2/3 3/3 3/3 1/3
0.01 ul 4/5 4/5 3/5 0/5 1/5 0/5 0/5 0/3 0/3 0/3 0/3 0/3 1/3 0/3 0/3 0/3 0/3 0/3
0.001 ul 1/5 2/5 1/5 0/5 0/5 0/5 0/5 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Qiagen AllPrep DNA/RNA mini kit Qiagen AllPrep DNA/RNA mini kit
blood HBB HBA ALAS2 CD3G ANK1 PBGD SPTB D3 vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA
5 ul 8/8 8/8 8/8 8/8 8/8 8/8 6/8 8/8 8/8 8/8 8/8 8/8 8/8 8/8 8/8 8/8 8/8 7/8
1 ul 8/8 8/8 8/8 8/8 5/8 5/8 5/8 8/8 8/8 5/8 4/8 8/8 8/8 8/8 4/8 8/8 4/8 4/8
0.1 ul 7/8 8/8 8/8 7/8 5/8 3/8 3/8 2/8 3/8 2/8 2/8 8/8 4/8 2/8 1/8 2/8 1/8 1/8
0.01 ul 6/8 6/8 7/8 2/8 1/8 0/8 0/8 1/8 1/8 1/8 1/8 2/8 1/8 0/8 0/8 0/8 1/8 0/8
0.001 ul 0/8 2/8 0/8 1/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8
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Table 3: Assessment of blood marker sensitivity using quantitative approach 
(input total RNA). Total RNA was extracted from blood samples from 5-6 different 
donors. A range of input total RNA was reverse transcribed and the resulting 
cDNA was amplified with the duplex and pentaplex systems. The dark squares 
represent positive results in all experiments, grey squares show positive results in 
some but not all experiments, white squares represent no positive result. 
 
 
 
HBA HBB ALAS2 CD3G ANK1 PBGD SPTB
10 ng RNA 5/5 5/5 5/5 5/5 5/5 5/5 5/5
1 ng RNA 5/5 5/5 5/5 5/5 5/5 4/5 5/5
0.1 ng RNA 6/6 6/6 6/6 5/6 3/6 2/6 4/6
0.01 ng RNA 6/6 6/6 5/6 5/6 2/6 0/6 0/6
0.001 ng RNA 5/5 4/5 1/5 1/5 1/5 0/5 1/5
0.0001 ng RNA 0/5 0/5 0/5 1/5 1/5 1/5 0/5
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Table 4: RNA and DNA typing results from 28 bona fide casework samples and 3 
mock samples (from proficiency trials / interlaboratory exercises). RNA and DNA 
were co-extracted with the AllPrep DNA/RNA Mini kit, 11 µl RNA were reverse 
transcribed, and resulting cDNA was amplified with duplex and pentaplex 
systems. DNA profiles were obtained with 5 µl DNA using the SGM plus kit. 
 
 
 
 
RNA DNA
delict stain age of stain (d) HBB HBA ALAS2 CD3G ANK1 PBGD SPTB D3 vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA ng/ul
1 assault 1/8 swab, rub-off from drops of blood 66 + + + + + + + + + + + + + + + + + + 1.17
2 proficiency trial blood on cotton pad, 5x5mm >2 years + + + + + - - + + + + + + + + + + + 0.08
3 proficiency trial blood on leather, 5x5mm >2 years + - - - - - - - - - - - - - - - - - 0
4 interlaboratory exercise textile, 5x5mm >11 years + + + - - - - + + + + + + + + + + + 0.05
5 burglary 1/4 swab, rub-off from doorknob terrace 32 + + + - - - - + + + + + + + + + + + 0.3
6 burglary 1/4 swab, rub-off from drop of blood from floor 32 + + + + + + + + + + + + + + + + + + 2.25
7 car break-in 1/4 swab, rub-off from passenger-side doorknob 
inside, closing button, glove box 39 + + + + - - - + + + + + + + + + + + 0.3
8 burglary 1/4 swab, rub-off from windowsill 38 - - - - - - - + + + + + + + + - + + 0.03
9 damage to property blood splatter  on wood, 2x2mm 54 + + + + + + + + + + + + + + + + + + 0.09
10 break traffic rules blood on drivers seat 39 + + + + - + - + + + + + + + + + + + 0.48
11 stabbing, bodily harm swab from a knife with blood 316 + + + + - - - + + + + + + + + + + + 0.61
12 bodily harm blood on blue jeans, 5x3mm 177 + + + + - + + + + + + + + + + + + + 0.28
13 bodily harm blood on T-Shirt, 3x7mm 177 + + + + + - + + + + + + + + + + + + 0.05
14 bodily harm swab from shoe sole with blood 177 + + + + - - - + + + + + + + + + + + 0.39
15 bodily harm thread from shoe with blood 177 + + + + - - - + + + + + + + + + + + 0.05
16 bodiiy harm blood on grey/white pullover, 5x5mm 183 + + + + - + - - - - - + + + + - + + 0.002
17 bodiiy harm swab from shoe sole with blood 178 + + + + - - - + + + + + + + + + + + 0.1
18 bodiiy harm checkered cap with blood, 3x3mm 178 + + + + + + + + + + + + + + + + + + 0.28
19 bodiiy harm little blood spot on shoe lace 178 + + + + + - - + + + + + + + + + + + 0.05
20 bodiiy harm blood on blue jeans, 1cm2 sraped off 178 + + + + + - - + + + + + + + + + + + 0.36
21 bodiiy harm blood on grey T-Shirt, 5x5mm 178 + + + + + + + + + + + + + + + + + + 0.65
22 bodiiy harm blood on light blue shirt, 4x4mm 178 + + + + + - + + + + + + + + + + + + 0.1
23 burglary 1/4 swab from windowsill outside, blood 32 + + + - + - - + + + + + + + + + + + 0.18
24 car break-in 1/4 swab from center console with blood 24 + + - - - - - + + + + + + + + + + + 0.09
25 damage to property 1/4 swab from doorknob car inside with blood 24 - - - - - - - + + + + + + + + + + + 0.14
26 burglary 1/4 swab from pane of door with blood 28 + + + + + - - + + + + + + + + + + + 4.61
27 damage to property paper towel with blood, 5x5mm 88 + + + + + + - + + + + + + + + + + + 0.61
28 burglary 1/8 swab from glass pane of door with blood 58 + - + + - - - + + + + + + + + + + + 2.83
29 robbery, damage to 
property
1/8 swab from blood drop on ground below 
window 67 + + + + + + + + + + + + + + + + + + 1.48
30 damage to property 1/4 swab from blood on engine hood 53 + + + - - - - + + + + + + + + + + + 0.81
31 damage to property swab from glass fragment with blood 53 - - - - - - - + + + + + + + + + + + 0.21
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Table 5: A set of blood samples was exposed to different environmental 
conditions including various temperatures and environmental influences like 
humidity and rain. RNA and DNA were co-extracted with the AllPrep DNA/RNA 
Mini kit, 8 μl RNA were reverse transcribed, cDNA was amplified with the 
multiplexes, 1 ng or the maximal volume of DNA was analyzed with the SGM plus 
kit. 
 
 
 
RNA DNA
Donor Exposure Cond. Length of Exposure HBB HBA ALAS2 CD3G ANK1 PBGD SPTB D3 vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA ng/ul
6 months + + + + + + + + + + + + + + + + + + 0.10
1 year + + + + + + - + + + - + + + + - + + 0.02
6 months + + + + + + + + + + - + + + + - + + 0.01
1 year + + + + + + + + + + + + + + + + + + 0.04
1 month + + + + + + + + + + + + + + + + + + 0.06
3 months + + + + + + + + + + + + + + + + + + 0.08
6 months + + + + + + + + + + + + + + + + + + 0.09
1 year + + + + - + - + + + + + + + + + + + 0.10
1 month + + + + + + + + + + - + + + + - + + 0.07
3 months + + + + + + + + + + + + + + + + + + 0.03
6 months + + + + + + + + + + + + + + + + + + 0.05
1 year + + + + + - - + + + + + + + + + + + 0.05
1 month + + + + + + + + + + + + + + + + + + 0.08
3 months + + + + + + - + + + + + + + + + + + 0.37
6 months + + + + + - - + + + + + + + + + + + 0.85
1 year + + + - + - - + + + + + + + + + + + 1.60
1 month + + + + + + + + + + + + + + + + + + 0.25
3 months + + + + - - - + + + + + + + + + + + 0.42
6 months + + + + + + + + + + + + + + + + + + 0.62
1 year + + + + + - - + + + + + + + + + + + 0.29
1 day + + + - + + - + + + + + + + + + + + 0.01
3 days + + - - - - - + + + + + + + + + + + 0.01
1 week + + + + + + + + + + + + + + + + + + 0.25
1 month + + + + + + + + + + + + + + + + + + 0.12
1 day + + + + + + + + + - - + + + - - - - 0.05
3 days + + + + + + + + + + + + + + + + + + 0.05
1 week + + + + + + + + + + - + + + + + + + 0.02
1 month + + + + + + + + + + + + + + + + + + 0.05
1 day + + + + + + - + + + + + + + + + + + 0.07
3 days + + + + + - - + + + + + + + + + + + 14.95
1 week + + + - + + + + + + + + + + + + + + 3.81
1 month + + - - - - - - - - - - - - - - - - 0.00
1 day + + + + + + + + + + + + + + + + + + 0.10
3 days + + + + + - + + + + + + + + + + + + 0.40
1 week + + + - - - - + + + + + + + + + + + 0.37
1 month + + + + - + - - - - - - - - - - - - 0.00
Female 1 0 + + + + + + + + + + + + + + + + + + 0.09
Female 2 0 + + + + + + + + + + + + + + + + + + 0.11
None
Female 1
Male 1
Male 1
Male 1
Female 1
Female 2
Outside, uncovered
37°C
37°C
Female 1
Male 1
Female 1
Male 1
Outside, covered
Outside, covered
Outside, uncovered
Room Temp
Room Temp
37°C
37°C
  35/38 
Table 6: Specificity of the blood mRNA markers – forensically relevant biological 
fluids. Total RNA was isolated from body fluid samples from overall 17 different 
donors. One nanogram of total RNA was reverse transcribed and the duplex and 
pentaplex used for subsequent amplification. The dark squares represent positive 
results in all experiments, grey squares show positive results in some but not all 
experiments, white squares represent no positive result.  
 
 
Duplex Pentaplex Singleplexes
Body fluid HBB HBA ALAS2 CD3G ANK1 PBGD SPTB HBB HBA ALAS2 CD3G ANK1 PBGD SPTB
blood 4/4 4/4 4/4 3/4 3/4 2/4 3/4 4/4 4/4 4/4 4/4 4/4 3/4 4/4
saliva 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
buccal swab 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
semen 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
vaginal secretions 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
menstrual blood 3/4 4/4 3/4 1/4 1/4 0/4 0/4 4/4 4/4 0/4 2/4 3/4 0/4 0/4
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Fig. 1: Duplex and pentaplex systems for the identification of blood. RT-PCR 
reactions were performed using 1 ng of total RNA isolated using a manual 
organic extraction. Amplification with the duplex (containing HBB - 61 bp; HBA - 
112 bp) and the pentaplex (ALAS2 - 133 bp, CD3G - 154 bp, ANK1 - 165 bp, 
PBGD - 177 bp, SPTB - 247 bp) was performed subsequent to the RT reaction. 
Representative electropherograms are shown, before (a,c) and after (b,d) post 
PCR purification, used to reduce the appearance of dye blobs (d) and saturation 
effects (*).  
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Electronic supplementary data 
 
Table S1: Blood specific genes and PCR primer sequences 
 
Gene Primer sequence Size (bp) Reference 
HBB f: GCA CGT GGA TCC TGA GAA C 
r: ATG GGC CAG CAC ACA GAC 
61 [14] 
HBA f: ACG CTG GCG AGT ATG GT 
r: CCC TTA ACC TGG GCA GAG 
112 new 
ALAS2 f: TGT GTC CGT CTG GTG TAG TA 
r: AAA CTT ACT GGT GCC TGA GA 
133 [16] 
CD3G f: GTC GAG AGC TTC AGA CAA GC 
r: AGG AGG AGA ACA CCT GGA CT 
154 new 
ANK1 f: GGC ATG CCC TAT TCT GTG 
r: CTT AGA AGC CAG ATG CAA GC 
165 new 
PBGD f. TGG ATC CCT GAG GAG GGC AGA AG 
r: TCT TGT CCC CTG TGG TGG ACA TAG 
CAA T 
177 [6] 
SPTB f: AGG ATG GCT TGG CCT TTA AT 
r: ACT GCC AGC ACC TTC ATC TT 
247 [6] 
AQP9 f: ATC GGC CTC CTG ATT ATT GT 
r: AAT GAC AGC ACC AAC CAA AG 
186 [13] 
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Table S2: Specificity testing with a) human tissues and b) animals. One 
nanogram of total RNA was reverse transcribed and the resulting cDNA amplified 
with the duplex and pentaplex. 
 
a Tissue HBB HBA ALAS2 CD3G ANK1 PBGD SPTB
Adipose + + + + - - +
Bladder + + + + - - -
Brain - + - - - - +
Cervix + + - + - - +
Colon - + + + - - +
Esophagus + + + + + + +
Heart - + - + - - +
Kidney - - - + - - +
Liver + + + + - - -
Lung + + + + - - +
Ovary - + - + - - +
Placenta - - - - - - -
Prostate - + + + - - -
Skeletal muscle - + + + - - +
Skin - + - + + - +
Small Intestine - - - + - - +
Spleen + + + + - - +
Testes + + + + + - +
Thymus + + - + - - +
Thyroid + + + + + - +
Trachea + + + + - - +
b Animal HBB HBA ALAS2 CD3G ANK1 PBGD SPTB
African Green Monkey + + + - - + +
Baboon + - + - - + +
Black Howler Monkey + - + - - - +
Brown Lemur - - + - - - -
Chimp + + + + - - -
Crab eating macaque + + + - - + +
Pig-tailed macaque + + + - - - +
Rhesus monkey + + + - - + +
Spider monkey - - + - - - -
Spot-nosed guenon - - + - - + +
Alligator - - + - + + -
Cat 1 + - - - - - -
Cat 2 + - + - - - -
Cow - - - - - - -
Deer - - - - - - -
Dog 1 + - - - - - -
Dog 2 + - - - - - -
Duck - - - - - - -
Ferret - - - - - - -
Frog - - - - - - -
Guinea Pig - - - - - - +
Goat - - - - - - -
Horse - - - - - - -
Mouse 1 - - + - - + -
Mouse 2 - - - - - + -
Opossum - - - - - - -
Pig - - - - - - -
Rabbit 1 - - + - - + +
Rabbit 2 - - + - - + -
Rat - - - - - + -
Rooster - - - - - - -
Sheep - - - - - - -
Turtle - - + + - + -
